Filing Flows

Filing Flows › 8-K events › TuHURA Biosciences

TuHURA Biosciences: creation of a direct financial obligation

Form 8-K filed Nov 6, 2026 · items 2.03

What the filing says

As previously disclosed, on April 21, 2026, TuHURA Biosciences, Inc. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Parkview Holdings One LLC, as lender. The Loan Agreement provides for a revolving credit facility that matures on April 21, 2031, with a maximum amount of loan availability of $

Read the filing on SEC EDGAR →

What usually followsAcross 13,268 8-Ks reporting Item 2.03 (new debt or off-balance-sheet obligation) in our universe, the stock's median move the next session was 0.0% (typical size ±1.3%, up 50% of the time); over the following 21 sessions, +1.2%. Every item ranked →

What this kind of filing means

Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.

Other recent debt and financing

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.